homehealthcare News

COVID 19 vaccine: Covishield, Covaxin price cut to Rs 225 for private hospitals

COVID-19 vaccine: Covishield, Covaxin price cut to Rs 225 for private hospitals

COVID-19 vaccine: Covishield, Covaxin price cut to Rs 225 for private hospitals
Profile image

By CNBCTV18.com Apr 9, 2022 4:41:02 PM IST (Updated)

COVID-19: Vaccine makers Serum Institute of India and Bharat Biotech have reduced the price of coronavirus vaccines Covishield and Covaxin to Rs 225, the companies announced on Saturday.

Domestic vaccine makers Serum Institute of India and Bharat Biotech have reduced the price of coronavirus vaccines Covishield and Covaxin to Rs 225 per dose, the companies announced on Saturday.

Recommended Articles

View All

“Announcing #CovaxinPricing . We welcome the decision to make available precautionary dose for all adults. In consultation with the Central Government, we have decided to revise the price of #COVAXIN from Rs 1200 to Rs 225 per dose, for #privatehospitals,” Bharat Biotech’s Co-Founder Joint Managing Director Suchitra Ella said in a tweet.
Adar Poonawalla, CEO of SII, too took to the microblogging site to say, “We are pleased to announce that after discussion with the Central Government, SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs.600 to Rs 225 per dose. We once again commend this decision from the Centre to open precautionary dose to all 18+.”
On Friday, SII said that the precaution dose of its Covishield vaccine will be priced at Rs 600 per shot for eligible individuals.
Bharat Biotech and Serum Institute’s announcements come a day after the Union Health Ministry said those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose.
According to the ministry, so far, about 96 percent of all those above the age of 15 years in India have received at least one vaccine dose, while about 83 percent have received both doses.
More than 2.4 crore precaution doses have also been administered to healthcare workers, frontline workers and those aged above 60 years.
The ongoing free COVID-19 inoculation programme through government vaccination centres for the first and the second dose to the eligible population as well as the precaution dose to healthcare workers, frontline workers and those above 60 years will be accelerated, the ministry added.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng